North America Pigmented Lesion Treatment Market

North America Pigmented Lesion Treatment Market Size (203 to 2028)

The size of the Pigmented Lesion Treatment Market in North America is estimated to grow at a robust CAGR during the forecast period.

Increasing the geriatric population suffering from various skin diseases is a primary growth factor to the North America Pigmented Lesion Treatment market. These have a wide variety of treatments with advanced technologies in treating various skin diseases that escalate the growth. The aging population, particularly those 60 years and above, is predicted to grow high by 2050, which means from 950 million in 2017 to 2.1 billion by 2050 is escalating the market growth. Investments for research, development of the treatment, growing intake of toxic substances like alcohol consumption, smoking, which leads to increased occurrence rate of pigmented lesions. The availability of a wide variety of laser technology treatments and the establishment of the new treatment and medication options that are safe and reliable with no adverse effects is considered to augment the market growth in this region.

The treatment cost is very high in this region when compared with other areas. The development of pigmentation devices has escorted to the improvement of patient safety. It has also reduced the side effects of pigmented lesion treatment, which restricts growth during the review period. Lack of awareness among the people for early diagnosis and the treatment related to it hampers the market.

This research report on The North America Pigmented Lesion Treatment Market has been segmented and sub-segmented into the following categories:

• By Product: Energy-Based Devices, RF Devices, Ultrasound Devices, and IPL Devices
• By End User: Beauty Clinics and Dermatology Clinics
• By Country: The United States, Canada and Rest of North America

Based on geography, North America accounted for the largest share of the Pigmented Lesion Treatment market. It can be accredited to the growing awareness among consumers regarding accessibility to various Pigmented Lesion Treatment devices. Factors such as the widespread presence of leading market players in the region and the availability of advanced skin treatment techniques are key factors governing the market growth in this region. Besides, a large portion of the geriatric population in this region is increasingly opting for skincare therapies to enhance their look and reduce the risk of skin-related diseases.

The U.S. is leading the market with the largest share over the period due to rising aesthetic awareness and typical growth of pigmented lesion treatment market of this region. Moreover, nearly 5.4 million new non-melanoma skin cancer cases are being recorded every year in this country, out of which 3.3 million are receiving the treatment bolster the growth in this region.

Canada is following the U.S in leading the market due to the growing elderly people population and the increasing aging population. Technological advancements for skin treatment techniques also fuel the market.

Companies leading the North America Pigmented Lesion Treatment Market profiled in this report are Alma Lasers Ltd., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences Inc., Fotona d.d., Sciton, Inc., EL.En. S.p.A., Lynton Lasers Ltd, Solta Medical Inc., Syneron Medical Ltd., Lutronic Corporation, and Cutera Inc.